These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25400246)

  • 1. The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    Microbiologyopen; 2014 Dec; 3(6):961-72. PubMed ID: 25400246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    J Bacteriol; 2015 Apr; 197(7):1173-84. PubMed ID: 25605307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability.
    Geng M; Smith L
    Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amino acid substitutions in conserved residues in the leader peptide on biosynthesis of the lantibiotic mutacin II.
    Chen P; Qi FX; Novak J; Krull RE; Caufield PW
    FEMS Microbiol Lett; 2001 Feb; 195(2):139-44. PubMed ID: 11179642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence analysis of mutA and mutM genes involved in the biosynthesis of the lantibiotic mutacin II in Streptococcus mutans.
    Woodruff WA; Novak J; Caufield PW
    Gene; 1998 Jan; 206(1):37-43. PubMed ID: 9461412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a Novel Lantibiotic Using Mutacin II Biosynthesis Apparatus.
    Biswas S
    Microbiol Spectr; 2023 Feb; 11(1):e0303022. PubMed ID: 36645288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
    Escano J; Ravichandran A; Salamat B; Smith L
    Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and dynamics of the lantibiotic mutacin 1140.
    Smith L; Zachariah C; Thirumoorthy R; Rocca J; Novák J; Hillman JD; Edison AS
    Biochemistry; 2003 Sep; 42(35):10372-84. PubMed ID: 12950164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Analysis of Mutacin B-Ny266, a Lantibiotic Active against Caries Pathogens.
    Dufour D; Barbour A; Chan Y; Cheng M; Rahman T; Thorburn M; Stewart C; Finer Y; Gong SG; Lévesque CM
    J Bacteriol; 2020 May; 202(12):. PubMed ID: 32229530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deuterium labeled peptides give insights into the directionality of class III lantibiotic synthetase LabKC.
    Krawczyk B; Ensle P; Müller WM; Süssmuth RD
    J Am Chem Soc; 2012 Jun; 134(24):9922-5. PubMed ID: 22687055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV.
    Qi F; Chen P; Caufield PW
    Appl Environ Microbiol; 2001 Jan; 67(1):15-21. PubMed ID: 11133423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic aspects of lanthipeptide leaders.
    Plat A; Kuipers A; Rink R; Moll GN
    Curr Protein Pept Sci; 2013 Mar; 14(2):85-96. PubMed ID: 23441895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production, purification, sequencing and activity spectra of mutacins D-123.1 and F-59.1.
    Nicolas GG; LaPointe G; Lavoie MC
    BMC Microbiol; 2011 Apr; 11():69. PubMed ID: 21477375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
    Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
    Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and partial characterization of the Streptococcus mutans type AII lantibiotic mutacin K8.
    Robson CL; Wescombe PA; Klesse NA; Tagg JR
    Microbiology (Reading); 2007 May; 153(Pt 5):1631-1641. PubMed ID: 17464078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of bacteriocins in Streptococcus mutans.
    Watanabe A; Kawada-Matsuo M; Le MN; Hisatsune J; Oogai Y; Nakano Y; Nakata M; Miyawaki S; Sugai M; Komatsuzawa H
    Sci Rep; 2021 Jun; 11(1):12963. PubMed ID: 34155274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutacin H-29B is identical to mutacin II (J-T8).
    Nicolas G; Morency H; LaPointe G; Lavoie MC
    BMC Microbiol; 2006 Apr; 6():36. PubMed ID: 16626493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of the antimicrobial mechanism of mutacin 1140.
    Smith L; Hasper H; Breukink E; Novak J; Cerkasov J; Hillman JD; Wilson-Stanford S; Orugunty RS
    Biochemistry; 2008 Mar; 47(10):3308-14. PubMed ID: 18266322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lantibiotics: insight and foresight for new paradigm.
    Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specific genes for lantibiotic mutacin II biosynthesis in Streptococcus mutans T8 are clustered and can be transferred en bloc.
    Chen P; Qi F; Novak J; Caufield PW
    Appl Environ Microbiol; 1999 Mar; 65(3):1356-60. PubMed ID: 10049909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.